
Dover (DOV) Stock Forecast & Price Target
Dover (DOV) Analyst Ratings
Bulls say
Dover has demonstrated resilience with organic sales growth of 4.6% year-over-year, in line with estimates, showcasing its capability to navigate market fluctuations. The company’s segment margins expanded significantly, reflecting improved operational efficiency and cost management, with notable growth in the Pumps & Process Solutions segment driven by high demand for biopharma components and digital controls. Furthermore, a strong 8% growth in bookings in the third quarter, largely attributed to the biopharma and climate technologies sectors, reinforces the company's positive outlook for continued revenue expansion.
Bears say
Dover's recent financial performance indicates a concerning trend, as total bookings-to-bill (BTB) fell below expectations at 0.96x, and organic sales for the Engineered Products and Climate & Sustainability Technologies segments declined by 6.1% and 6.5%, respectively. The company's margins have also diminished, decreasing by 40 basis points year-over-year to 19.2%, primarily due to weaker demand in vehicle wash solutions. Additionally, Dover's valuation metrics reflect a significant discount relative to peers, with a price-to-earnings (P/E) ratio of 17.1x for 2026 EPS estimates, suggesting potential challenges that could stem from deteriorating industrial demand and operational missteps.
This aggregate rating is based on analysts' research of Dover and is not a guaranteed prediction by Public.com or investment advice.
Dover (DOV) Analyst Forecast & Price Prediction
Start investing in Dover (DOV)
Order type
Buy in
Order amount
Est. shares
0 shares